Purchase Order N0017319P0020
- Not listed
- This is a firm fixed-price delivery order awarded by the National Institute on Aging, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $872,996.22 award is for the provision of Illumina reagent kits to support genomic analysis and sequencing work. This order falls under a larger Indefinite Delivery Contract that Illumina holds with the Department of the Navy's Bureau of Medicine and...
- The Office of Naval Research awarded a $16,302 firm fixed-price purchase order to Illumina, Inc. for reagent kits on September 26, 2013, with completion targeted for October 26, 2013. The contract, issued without a set-aside designation, will be performed in San Diego, California. Illumina is a biotechnology company specializing in genetic sequencing and genomic analysis technologies, providing DNA and RNA sequencing instruments, reagents, consumables, and bioinformatics software to federal...
- This federal contract award, valued at $161,610.94, was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Illumina, Inc. as the prime contractor. The award is for the delivery of various Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis. This appears to be a delivery order under a larger Indefinite Delivery Contract that Illumina holds with the Department of the Navy Bureau of Medicine and...
- This federal contract award was issued by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health, to Illumina, Inc. The $230,179.20 firm fixed price delivery order contract is for the provision of various Illumina sequencing systems, reagents, and supporting services. The contract has no set-aside designation. Illumina has previously been awarded prime federal contracts and sub-grants by other agencies such as the CDC, USDA, and VA to provide...
- This is a firm fixed-price delivery order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $248,854.86 contract is for the procurement of NovaSeq X Series reagent kits, including 1.5B, 25B, and 10B cycle kits, to support genomic research and diagnostic applications. The contract does not have a set-aside designation. Illumina has been...
- The federal contract award was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $86,847.02 firm fixed price delivery order supports the provision of Illumina's sequencing systems, consumables, and maintenance services. This award is associated with a larger Indefinite Delivery Contract (IDC) between Illumina and the Department of the Navy, valued up to $3.3...
- This $118,914.05 firm-fixed-price delivery order was awarded by the Department of Health and Human Services, National Institutes of Health, National Institute on Aging to Illumina, Inc., a manufacturer of genomic sequencing and analysis instruments and reagents. The award does not have a set-aside designation. Illumina has previously received prime federal contracts from agencies such as the NIH, CDC, USDA, and VA to provide sequencing platforms, reagents, and related bioinformatics support...
- The U.S. Department of Health and Human Services Food and Drug Administration awarded a firm fixed price delivery order worth $206,046.90 to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The award is for the provision of "REAGENT (CHEMISTRY) KITS" and does not include any set-aside designation. Illumina has previously received prime federal contract awards from agencies such as the NIH, CDC, USDA, and VA to provide a range of genomic sequencing technologies...
- This federal contract award to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency. The $20,198.50 firm fixed price purchase order does not have a set-aside designation. The contract is for the procurement of Illumina's advanced sequencing instruments, reagents, consumables, and bioinformatics software to support scientific research, healthcare, and...
- This is a $116,924.36 firm fixed price delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The order is for the provision of biological kits and reagents, with no set-aside designation. Through past prime federal contract awards, Illumina has supplied a range of sequencing systems, consumables, and services to support genomic...
This federal contract award was issued by the Office of Naval Research (ONR), a defense agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $23,256.48 firm fixed-price purchase order is for a reagent kit (PR# 69-5525-18) with a completion date of November 26, 2018. The contract does not utilize any set-aside designations. Illumina is a specialized technology provider that has been awarded numerous prime federal contracts and grants across agencies like the NIH, CDC, USDA, VA, and FDA, primarily for the procurement of advanced sequencing instruments, reagents, and associated services. The company holds Indefinite Delivery Vehicles with the VA valued at over $1.5 million, enabling the flexible acquisition of Illumina's genomic sequencing platforms and support to meet the agency's evolving research and diagnostic needs.